0001209191-23-013215.txt : 20230227 0001209191-23-013215.hdr.sgml : 20230227 20230227165118 ACCESSION NUMBER: 0001209191-23-013215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fitzgerald Kevin Joseph CENTRAL INDEX KEY: 0001886431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 23676026 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-23 0 0001636651 Ovid Therapeutics Inc. OVID 0001886431 Fitzgerald Kevin Joseph C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE NEW YORK NY 10001 1 0 0 0 Stock Option (Right to Buy) 2.50 2023-02-23 4 A 0 15000 0.00 A 2033-02-22 Common Stock 15000 15000 D The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date. /s/ Danielle Mann for Kevin Fitzgerald by PoA 2023-02-27